ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Braftovi 75 mg, Hartkapseln - 42
66795002 Pierre Fabre Pharma SA
Braftovi 75 mg, Hartkapseln01.11.2019
  01.11.2019
Encorafenib (L01EC03) 
WHO-DDD 
07.16.10.42
07.16.10. 
A  
Yes 
IPCI
1256.61Yes
    
10 %1383.05
  
7680667950028Synthetika
7755145 
Composition
encorafenibum 75 mg, copovidonum K 28, poloxamerum 188, cellulosum microcristallinum, acidum succinicum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), Drucktinte: lacca, E 172 (nigrum), pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Encorafenibum75 mg
BAG: Active AgentDose
Encorafenibum75 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
(Rubrum)  
Succinic Acid  
Cellulosum Microcristallinum  
Copovidonum K28  
Crospovidonum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Lacca Drucktinte
Magnesii Stearas  
Poloxamer188  
Pro Capsula  
Silica Colloidalis Anhydrica  
 
Source
Data was imported : 19.11.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | Login | Contact | Home